Stocktoria

Rezolute, Inc. RZLT

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2011-12-23 · LEI

Rezolute, Inc. statistics & valuation

Market cap$485.3M
P / B3.0×
Return on equity-45.9%
Return on capital-48.8%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
2016201720182019202020212022202320242025
Return on equity (%)
-170.20% -237.80% -1737.80% -276.10% -80.10% -27.50% -44.60% -56.60% -45.90% 2016201720182019202020212022202320242025
Shares outstanding
35.1M 49.2M 62166 4.2M 5.9M 8.4M 33.6M 51.2M 53.2M 87.0M 2016201720182019202020212022202320242025
Net debt ($)
$1.8M -$37.6M -$77.4M -$27.1M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-137.00% -190.80% -1193.00% -248.50% -185.40% -49.10% -26.90% -41.90% -51.60% -42.40% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
0.00× 0.00× 0.54× 2016201720182019202020212022202320242025
EPS ($)
-$2.72 -$2.32 -$1.01 -$1.33 -$0.98 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Return on assets-42.4%-51.6%-41.9%-26.9%-49.1%-185.4%-248.5%-1193.0%-190.8%-137.0%
Return on equity-45.9%-56.6%-44.6%-27.5%-80.1%-276.1%-1737.8%753.9%-237.8%-170.2%
Debt / equity————0.54×0.00×0.00×-0.86×——
Current ratio14.3713.3920.1861.7821.343.261.450.322.782.60

Computed from company filings · US · as of 2025-06-30. Facts plus Stocktoria's own computed scores — not investment advice.